Activity of hippocampal CA1 neurons in Alzheimer's disease is not affected by the presence of adjacent neuritic plaques

Journal of Alzheimer's Disease

Volumn 1, Issue 2, 1998, Pages 107-118

  Salehi, A ^a   Pool, C W ^a   Mulder, M ^a   Ravid, R ^a   Gonatas, N K ^a   Swaab, D F ^a  

^a NETHERLANDS INSTITUTE FOR NEUROSCIENCE   (Netherlands)

Author keywords

Alzheimer; ApoE; CA1 area; Golgi apparatus; Hippocampus; Neuritic plaque

Indexed keywords

APOLIPOPROTEIN E;

AGED; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; FEMALE; GENOTYPE; GOLGI COMPLEX; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; NERVE CELL; PRIORITY JOURNAL; SENILE PLAQUE;

EID: 0032229653     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-1998-1204     Document Type: Article

References (50)

1. Diagnosis of Alzheimer's disease
2. Clinical diagnosis of Alzheimer's disease. Report of NINCDS-ADRDA Work Group under the Auspices of Department of Health and Human Services Task Force on Alzheimer's Disease
3. The association between quantitative measures of dementia and of senile changes in the cerebral grey matter of elderly subjects
4. Abnormal phosphorylation of the microtubule-associated protein tau in Alzheimer cytoskeletal pathology
5. Microtubule-associated protein tau, a component of paired helical filaments
6. Identification and localization of a tau peptide at paired helical filaments of Alzheimer disease
7. Biopsy-derived adult human brain tau is phosphorylated at the same sites as Alzheimer's disease paired helical
8. The presence of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptors
9. Amyloid β-protein gene: cDNA, mRNA distribution, and genetic linkage near the Alzheimer locus
10. Cortical neuronal counts in normal elderly controls and demented patients
11. Structural basis of the cognitive alterations in Alzheimer Disease. Alzheimer Disease
12. Hippocampal formation: Anatomy and the patterns of pathology in Alzheimer's disease
13. Diffuse plaques do notaccentuate synapse loss in Alzheimer's disease
14. Senile plaques do not progressively accumulate with normal aging
15. Glucose metabolism as the site of the primaryabnormality in early-onset dementia of Alzheimer type?
16. Cognitive impairment in Alzheimer's disease correlates with ventricular with and atrophy-corrected cortical glucose metabolism
17. In vitro protein synthesis by messenger RNA from the Alzheimer's disease brain
18. Chemical pathology of the organic dementias
19. Neuronal RNA in relation to neuronal loss and neurofibrillary pathology in the hippocampus in Alzheimer's disease
20. Alterations in protein synthetic capability of nerve cells in Alzheimer's disease
21. Decreased neuronal activity in the nucleus basalis of Meynert in Alzheimer's disease as suggested by the size of the Golgi apparatus
22. Decreased activity of the hippocampal neurons in Alzheimer's disease is not related to the presence of the neurofibrillary tangles
23. Decreased protein synthetic activity of the hypothalamic tuberomamillary nucleus in Alzheimer's disease as suggested by the size of the Golgi apparatus
24. The Golgi apparatus complex (1954-1981) from artifact to centre stage
25. Quantitative histochemical study on the influence of lactation and changing levels of gonadotropic hormones on rat supraoptic nucleus
26. Differences in the pattern of hippocampal neuronal loss in normal ageing and Alzheimer's disease
27. The Global Deterioration Scale for assessment of primary degenerative dementia
28. Immunocytochemical visualization of the Golgi apparatus in several species, including human, and tissues with an antiserum against MG-160, a sialoglycoprotein of rat Golgi apparatus
29. MG-160: A novel sialoglycoprotein of the medial cisternae of the Golgi apparatus
30. The Golgi apparatus of motor neurons in amyotrophic lateral sclerosis
31. Asignment of the GLG1 gene for MG-160, a fibroblast growth factor and E-selection binding membrane sialoglycoprotein of the Golgi apparatus, to chromosome 16q22-23 by fluorescence in situ hybridization
32. MG-160, a membrane protein of the Golgi apparatus which is homologous to a fibroblast growth factor receptor, and to a ligand for E-selectin, is found only in the Golgi apparatus, and appears early in chicken embryo
33. A hypothesis on the traffic of MG-160, a medial Golgi sialoglycoprotein, from the trans-Golgi network to the Golgi cisternae
34. Activation of human supraoptic and paraventricular nucleus neurons with aging and in Alzheimer's disease as judged from increasing size of the Golgi apparatus
35. Antigen retrieval in formalin-fixed, paraffin-embedded tissues: A enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections
36. Heavy metal intensification of DAB-based HRP reaction product
37. A new method for staining nerve fibres and nerve endings in mounted paraffin sections
38. A variety of cerebral deposition in the brains of the Alzheimer-type dementia demonstrated by beta protein immunostaining
39. Limited effects of neuritic plaques on neuronal density on the hippocampal CA1 area of Alzheimer patients
40. Apolipoprotein E4 allele as a predictor of cholinergic deficits and treatment outcome in Alzheimer's disease
41. Aggravated decrease in the activity of nucleus basalis neurons in Alzheimer's disease is apolipoprotein E-type dependent
42. Increased amyloid beta-peptide deposition in cerebral consequence of apolipoprotein E genotype in late-onset disease
43. Single-day apolipoprotein E genotyping
44. Brain aging and Alzheimer's disease: 'wear and tear' versus 'use it or lose it'
45. Early cytoskeletal changes as shown by Alz-50 are not accompanied by decreased neuronal activity
46. Possible role of apoptosis in Alzheimer's disease
47. A potential role for apoptosis in neurodegeneration and Alzheimer's disease
48. Increased expression of the TIAR protein in the hippocampus of Alzheimer patients
49. Rating of the lesions in senile dementia of the Alzheimer type: Concordance between laboratories. A European multicenter study under the auspices of EURAGE
50. Making the diagnosis of Alzheimer's disease